Evidence map›Paper›PMID 27112127›Full record

ArticleScientific reports2016

Combining measurements to estimate properties and characterization extent of complex biochemical mixtures; applications to Heparan Sulfate.

Joël R Pradines, Daniela Beccati, Miroslaw Lech, Jennifer Ozug, Victor Farutin, Yongqing Huang, Nur Sibel Gunay, Ishan Capila

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Joël R PradinesMomenta Pharmaceuticals Inc., Research Department, Cambridge, MA 02142, USA.
Daniela BeccatiMomenta Pharmaceuticals Inc., Research Department, Cambridge, MA 02142, USA.
Miroslaw LechMomenta Pharmaceuticals Inc., Research Department, Cambridge, MA 02142, USA.
Jennifer OzugMomenta Pharmaceuticals Inc., Research Department, Cambridge, MA 02142, USA.
Victor FarutinMomenta Pharmaceuticals Inc., Research Department, Cambridge, MA 02142, USA.
Yongqing HuangMomenta Pharmaceuticals Inc., Research Department, Cambridge, MA 02142, USA.
Nur Sibel GunayMomenta Pharmaceuticals Inc., Research Department, Cambridge, MA 02142, USA.
Ishan CapilaMomenta Pharmaceuticals Inc., Research Department, Cambridge, MA 02142, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Complex mixtures of molecular species, such as glycoproteins and glycosaminoglycans, have important biological and therapeutic functions. Characterization of these mixtures with analytical chemistry measurements is an important step when developing generic drugs such as biosimilars. Recent developments have focused on analytical methods and statistical approaches to test similarity between mixtures. The question of how much uncertainty on mixture composition is reduced by combining several measurements still remains mostly unexplored. Mathematical frameworks to combine measurements, estimate mixture properties, and quantify remaining uncertainty, i.e. a characterization extent, are introduced here. Constrained optimization and mathematical modeling are applied to a set of twenty-three experimental measurements on heparan sulfate, a mixture of linear chains of disaccharides having different levels of sulfation. While this mixture has potentially over two million molecular species, mathematical modeling and the small set of measurements establish the existence of nonhomogeneity of sulfate level along chains and the presence of abundant sulfate repeats. Constrained optimization yields not only estimations of sulfate repeats and sulfate level at each position in the chains but also bounds on these levels, thereby estimating the extent of characterization of the sulfation pattern which is achieved by the set of measurements.

Indexed as

Models, TheoreticalDrugs, GenericHeparan SulfateHeparin LyaseSulfatesDrugs, GenericHeparan SulfateHeparin LyaseSulfates

Identifiers

PMID27112127
PMCPMC4845011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.